메뉴 건너뛰기




Volumn 13, Issue 5, 2011, Pages 480-484

Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population

Author keywords

Acyclovir; Autologous; Reactivation; Shingles; Transplant; Varicella zoster

Indexed keywords

ACICLOVIR; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; MELPHALAN; MORPHINE; THIOTEPA;

EID: 80053580245     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00655.x     Document Type: Article
Times cited : (24)

References (10)
  • 1
    • 0034748416 scopus 로고    scopus 로고
    • Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation
    • Kanda Y, Mineishi S, Saito T, et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28 (7): 689-692.
    • (2001) Bone Marrow Transplant , vol.28 , Issue.7 , pp. 689-692
    • Kanda, Y.1    Mineishi, S.2    Saito, T.3
  • 2
    • 0035873217 scopus 로고    scopus 로고
    • A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation
    • Offidani M, Corvatta L, Olivieri A, et al. A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation. Clin Infect Dis 2001; 32 (10): 1414-1422.
    • (2001) Clin Infect Dis , vol.32 , Issue.10 , pp. 1414-1422
    • Offidani, M.1    Corvatta, L.2    Olivieri, A.3
  • 3
    • 62749111502 scopus 로고    scopus 로고
    • Herpes zoster (shingles) and postherpetic neuralgia
    • Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc 2009; 84 (3): 274-280.
    • (2009) Mayo Clin Proc , vol.84 , Issue.3 , pp. 274-280
    • Sampathkumar, P.1    Drage, L.A.2    Martin, D.P.3
  • 5
    • 79953211185 scopus 로고    scopus 로고
    • High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation
    • Oct 25 [Epub ahead of print].
    • Su SH, Martel-Laferrière V, Labbé A, et al. High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010 Oct 25 [Epub ahead of print].
    • (2010) Biol Blood Marrow Transplant
    • Su, S.H.1    Martel-Laferrière, V.2    Labbé, A.3
  • 6
    • 80053600672 scopus 로고    scopus 로고
    • National Comprehensive Cancer Network Inc. Prevention and treatment of cancer-related infections, version 1.2011. Available at Accessed 2011 May 9.
    • National Comprehensive Cancer Network Inc. Prevention and treatment of cancer-related infections, version 1.2011. Available at Accessed 2011 May 9.
  • 7
    • 84921537511 scopus 로고    scopus 로고
    • Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
    • Dykewicz CA, Jaffe HW, Kaplan JE, et al. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000; 49: 1-125.
    • (2000) MMWR Recomm Rep. , vol.49 , pp. 1-125
    • Dykewicz, C.A.1    Jaffe, H.W.2    Kaplan, J.E.3
  • 8
    • 69849102119 scopus 로고    scopus 로고
    • Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective
    • Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15 (10): 1143-1238.
    • (2009) Biol Blood Marrow Transplant , vol.15 , Issue.10 , pp. 1143-1238
    • Tomblyn, M.1    Chiller, T.2    Einsele, H.3
  • 9
    • 35548939933 scopus 로고    scopus 로고
    • One year acyclovir prophylaxis for preventing varicella zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation
    • Erard V, Guthrie KA, Varley C, et al. One year acyclovir prophylaxis for preventing varicella zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood 2007; 110 (8): 3071-3077.
    • (2007) Blood , vol.110 , Issue.8 , pp. 3071-3077
    • Erard, V.1    Guthrie, K.A.2    Varley, C.3
  • 10
    • 85027928908 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT
    • Klein A, Miller KB, Sprague K, DesJardin JA, Snydman DR. A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT. Bone Marrow Transplant 2011; 46 (2): 294-299.
    • (2011) Bone Marrow Transplant , vol.46 , Issue.2 , pp. 294-299
    • Klein, A.1    Miller, K.B.2    Sprague, K.3    DesJardin, J.A.4    Snydman, D.R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.